NCT00517543View on ClinicalTrials.gov

A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease (COPD)Rheumatoid ArthritisAtherosclerosis
Interventions
DRUG

GW856553

Trial Locations (1)

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY